Skip to main content
 

Our Valsartan News

Below are some of our news stories explaining the dangers of Valsartan contaminating with N-nitrosodimethylamine (NDMA). To learn about the legal claims that have been filed, click Valsartan.

 
Friday, February 10, 2023

A federal court sitting in New Jersey has just issued an order green-lighting a class action lawsuit against several manufacturers of generic

Tuesday, January 14, 2020

Drugmaker Mylan Pharmaceuticals, Inc. has issued a…

Friday, August 16, 2019

This month, a fourth Indian drug company involved in the manufacture of valsartan and another angiotensin II receptor blockers (ARBs) received an FDA warning letter over NDEA and NDMA found in its…

Wednesday, January 2, 2019

Aurobindo Pharma USA, Inc. has issued a voluntary recall of three of its sartan-based prescription medications after discovering trace amounts of a carcinogenic substance known as N-…

Thursday, November 15, 2018

For the second time in as many weeks, the Food and Drug Administration has notified physicians and patients…

Friday, September 14, 2018

Only a few months ago, government health authorities in Europe and the U.S.…

Thursday, August 2, 2018

Last month, the China-based Zhejiang Huahai Pharmaceutical Company informed the European Medicines Agency that one of their products used in the treatment of hypertension, known as…

Subscribe to Valsartan News